MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Tuesday, June 6, 2017

1:45pm-3:15pm
Disease-modification in Translational Models of Parkinson’s disease by the Rho Kinase Inhibitor Fasudil

L. Tönges, L. Tatenhorst, J. Koch, T. Outeiro, M. Zweckstetter, M. Bähr, P. Lingor (Bochum, Germany)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Does cerebellar dysfunction contribute to tremor in Parkinson’s disease?

E. Batzianouli, M. Pagliaro, D. Benninger (Lausanne, Switzerland)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Does Parkinsons KinetiGraph (PKG) recording help in clinical decision making? A local experience

N. Wilson, R. Mappilakkandy, M. Smith, K. Nithi (Northampton, United Kingdom)

Technology  ·  Exhibit Hall C
1:45pm-3:15pm
Dopamine Agonists and Postural Disorders in Parkinson’s disease

L. Ameghino, V. Bruno, M. Merello (Buenos Aires, Argentina)

Drug-Induced Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Dopamine replacement medication improves acquisition, retention, and transfer of skilled upper extremity movement in people with Parkinson Disease.

S. Paul, C. Walter, G. Olivier, L. Dibble, S. Schaefer (Salt Lake City, UT, USA)

Therapy in Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Dopamine substitution restores effective connectivity between prefrontal and premotor areas in Parkinson’s disease

P. Loehrer, F. Nettersheim, F. Jung, I. Weber, C. Huber, T. Dembek, E. Pelzer, M. Tittgemeyer, L. Timmermann (Marburg, Germany)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Dopamine transporter scan finding in patients with chorea.

K. Kawabe, K. Miura, K. Ikeda, Y. Iwasaki (Tokyo, Japan)

Huntington's Disease  ·  Exhibit Hall C
1:45pm-3:15pm
Down-regulation of miR-9* in the peripheral leukocytes of Huntington’s Disease patients

K.-H. Chang, Y.-R. Wu, C.-M. Chen (Taoyuan County, Taiwan)

Huntington's Disease  ·  Exhibit Hall C
1:45pm-3:15pm
Drug-induced movement disorders: not a typical problem

A. Vives-Rodriguez, A. Patel (New Haven, CT, USA)

Drug-Induced Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Dural lymphatic vasculature in human superior saggital sinus: the brain drain

N. Visanji, A. Lang, D. Munoz (Toronto, ON, Canada)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 38
  • Next Page»

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley